Objective: To summarize recent data and knowledge of secondary prevention of the recurrence of intrauterine adhesions in patients with Ashermans syndrome.
Methods: Analysis of literature evidence and clinical experience of the authors.
Results: Ashermans syndrome is iatrogenic disease with problematic therapy.